These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 16868020)

  • 1. Submaximal exercise testing in the assessment of interstitial lung disease secondary to systemic sclerosis: reproducibility and correlations of the 6-min walk test.
    Buch MH; Denton CP; Furst DE; Guillevin L; Rubin LJ; Wells AU; Matucci-Cerinic M; Riemekasten G; Emery P; Chadha-Boreham H; Charef P; Roux S; Black CM; Seibold JR
    Ann Rheum Dis; 2007 Feb; 66(2):169-73. PubMed ID: 16868020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Limitations to the 6-minute walk test in interstitial lung disease and pulmonary hypertension in scleroderma.
    Garin MC; Highland KB; Silver RM; Strange C
    J Rheumatol; 2009 Feb; 36(2):330-6. PubMed ID: 19208563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance capacity evaluated using the 6-minute walk test: 5-year results in patients with diffuse systemic sclerosis and initial interstitial lung disease.
    Rizzi M; Sarzi-Puttini P; Airoldi A; Antivalle M; Battellino M; Atzeni F
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S142-7. PubMed ID: 26339893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective, longitudinal study evaluating the baseline six-minute walk test as an individual reference value in systemic sclerosis patients.
    Vandecasteele E; Melsens K; De Keyser F; De Pauw M; Deschepper E; Decuman S; Piette Y; Thevissen K; Brusselle G; Smith V
    Clin Exp Rheumatol; 2018; 36 Suppl 113(4):95-101. PubMed ID: 30183593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ventilation distribution as a contributor to the functional exercise capacity in patients with systemic sclerosis-associated interstitial lung disease without pulmonary hypertension.
    Andrade FM; Oliveira AD; Lopes AJ
    Braz J Med Biol Res; 2019; 52(8):e8513. PubMed ID: 31365695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of progression of interstitial lung disease in patients with systemic sclerosis: the SPAR model.
    Wu W; Jordan S; Becker MO; Dobrota R; Maurer B; Fretheim H; Ye S; Siegert E; Allanore Y; Hoffmann-Vold AM; Distler O
    Ann Rheum Dis; 2018 Sep; 77(9):1326-1332. PubMed ID: 29875097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of physiological responses after incremental shuttle walking test and 6-minute walk test in patients with systemic sclerosis.
    Ozcan Kahraman B; Tanriverdi A; Sezgin NH; Acar S; Birlik AM; Koken Avsar A; Akdeniz B; Ozpelit E; Savci S
    Wien Klin Wochenschr; 2024 Mar; 136(5-6):169-176. PubMed ID: 36161531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ability of the COPD Assessment Test to evaluate the lung-specific quality of life in systemic sclerosis-associated interstitial lung disease.
    Mugii N; Someya F
    Clin Respir J; 2020 Jun; 14(6):527-532. PubMed ID: 32045097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Six-minute walk test in systemic sclerosis: A systematic review and meta-analysis.
    Vandecasteele E; De Pauw M; De Keyser F; Decuman S; Deschepper E; Piette Y; Brusselle G; Smith V
    Int J Cardiol; 2016 Jun; 212():265-73. PubMed ID: 27057932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors relating to impaired stroke volume during the 6-minute walk test in patients with systemic sclerosis.
    Someya F; Mugii N; Oohata S
    Clin Exp Rheumatol; 2016; 34 Suppl 100(5):152-156. PubMed ID: 27463117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 1-minute sit-to-stand test to detect exercise-induced oxygen desaturation in patients with interstitial lung disease.
    Briand J; Behal H; Chenivesse C; Wémeau-Stervinou L; Wallaert B
    Ther Adv Respir Dis; 2018; 12():1753466618793028. PubMed ID: 30091679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limited Exercise Capacity in Patients with Systemic Sclerosis: Identifying Contributing Factors with Cardiopulmonary Exercise Testing.
    Martis N; Queyrel-Moranne V; Launay D; Neviere R; Fuzibet JG; Marquette CH; Leroy S
    J Rheumatol; 2018 Jan; 45(1):95-102. PubMed ID: 29093153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical algorithms for the diagnosis and prognosis of interstitial lung disease in systemic sclerosis.
    Hax V; Bredemeier M; Didonet Moro AL; Pavan TR; Vieira MV; Pitrez EH; da Silva Chakr RM; Xavier RM
    Semin Arthritis Rheum; 2017 Oct; 47(2):228-234. PubMed ID: 28454677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interstitial lung disease in systemic sclerosis.
    Bussone G; Mouthon L
    Autoimmun Rev; 2011 Mar; 10(5):248-55. PubMed ID: 20863911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severity and features of frailty in systemic sclerosis-associated interstitial lung disease.
    Guler SA; Kwan JM; Winstone TA; Milne KM; Dunne JV; Wilcox PG; Ryerson CJ
    Respir Med; 2017 Aug; 129():1-7. PubMed ID: 28732817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of mycophenolate mofetil (MMF) on systemic sclerosis-related interstitial lung disease with mildly impaired lung function: a double-blind, placebo-controlled, randomized trial.
    Naidu GSRSNK; Sharma SK; Adarsh MB; Dhir V; Sinha A; Dhooria S; Jain S
    Rheumatol Int; 2020 Feb; 40(2):207-216. PubMed ID: 31813058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary function tests as outcomes for systemic sclerosis interstitial lung disease.
    Caron M; Hoa S; Hudson M; Schwartzman K; Steele R
    Eur Respir Rev; 2018 Jun; 27(148):. PubMed ID: 29769294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The six-minute walk test using forehead oximetry is reliable in the assessment of scleroderma lung disease.
    Wilsher M; Good N; Hopkins R; Young P; Milne D; Gibson A; Suppiah R; Ly J; Doughty R; Dalbeth N
    Respirology; 2012 May; 17(4):647-52. PubMed ID: 22256786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of Forced Vital Capacity and Lung Diffusion Cutpoints for Associated Radiographic Interstitial Lung Disease in Systemic Sclerosis.
    Showalter K; Hoffmann A; Rouleau G; Aaby D; Lee J; Richardson C; Dematte J; Agrawal R; Chang RW; Hinchcliff M
    J Rheumatol; 2018 Nov; 45(11):1572-1576. PubMed ID: 30275265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of six-minute walk test in systemic sclerosis.
    Rizzi M; Radovanovic D; Santus P; Airoldi A; Frassanito F; Vanni S; Cristiano A; Sarzi-Puttini P; Atzeni F
    Clin Exp Rheumatol; 2018; 36 Suppl 113(4):161-167. PubMed ID: 30277863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.